Stockreport

PTC Therapeutics Announces Topline Results of CardinALS Trial of Utreloxastat in ALS Patients [Yahoo! Finance]

PTC Therapeutics, Inc.  (PTCT) 
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ptcbio.com
PDF WARREN, N.J. Nov. 26, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the global Phase 2 placebo-controlled CardinALS study did not meet [Read more]